Related Experiment Videos
Overview: transplantation tolerance--challenges and opportunities for drug development
1Merck Research Laboratories, Rahway, NJ 07065, USA. francis_dumont@merck.com
Current Opinion in Investigational Drugs (London, England : 2000)
|November 15, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Novel pharmacological modulators of autophagy and therapeutic prospects.
Expert opinion on therapeutic patents·2012
Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy.
Current cancer drug targets·2012
Fontolizumab Protein Design Labs.
Current opinion in investigational drugs (London, England : 2000)·2005
Fingolimod. Mitsubishi Pharma/Novartis.
IDrugs : the investigational drugs journal·2005
Technology evaluation: abatacept, Bristol-Myers Squibb.
Current opinion in molecular therapeutics·2004
ISAtx-247 (Isotechnika/Roche).
Current opinion in investigational drugs (London, England : 2000)·2004
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.
Journal of psychosomatic research·2026
Alemtuzumab Induction via Intravenous vs. Subcutaneous Administration in Pediatric Kidney Transplantation.
Pediatric transplantation·2026
Integrating Deceased and Living Donation: Six-Year Outcomes of the Italian Deceased-Donor-Initiated Kidney Paired Exchange (DEC-K) Program.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026